TScan Therapeutics
TCRX
TCRX
28 hedge funds and large institutions have $69.9M invested in TScan Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
5
Increased
8
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$3.16M |
2 |
NM
2
Newtyn Management
New York
|
$0 |
3 |
BCM
3
Bridgeway Capital Management
Houston,
Texas
|
$125K |
4 |
4
Morgan Stanley
New York
|
$271K |
5 |
CC
5
Cannell Capital
Alta,
Wyoming
|
$0 |